Executive Overview: The Global Metformin Hydrochloride Market Metformin Hydrochloride stands as a cornerstone therapeutic agent​ in global diabetes management, with the market valued at $258.40 million in 2022​ and projected to reach $342.30 million by 2030, reflecting a steady 4.10% CAGR​ . This first-line oral antidiabetic medication serves approximately 537 million adults​ worldwide living with diabetes—a number expected to rise to 643 million by 2030​ according to the International Diabetes Federation . The market demonstrates robust trading activity with 170,635 import shipments​ recorded annually, involving 11,508 buyers​ across 199 importing countries​ . Understanding the global buyer landscape requires analyzing key pharmaceutical players, regional consumption patterns, and evolving procurement strategies in…